Esprinet Spa, the Technology sector company, was revisited by a Wall Street analyst today. Analyst Pietro Nargi from Intermonte maintained a Buy rating on the stock and has a €7.00 price target.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Pietro Nargi has given his Buy rating due to a combination of factors, including solid operating performance and a still-attractive valuation versus his €7.0 target price. Despite a temporary hit to net profit from a higher tax rate and weakness in the Devices division, the company is delivering steady revenue growth, disciplined cost control, and robust cash generation, supported by strong momentum in Solutions and Green Tech.
Nargi also views the CEO transition as orderly and low‑risk, given that the incoming chief executive has been deeply involved in the business since 2016 and the outgoing CEO remains a significant shareholder. While he trims earnings forecasts slightly to reflect a different revenue mix, he expects rising selling prices, improving margins, and double-digit growth in Iberia to support higher profitability, justifying a continued Buy recommendation.
Nargi covers the Technology sector, focusing on stocks such as Esprinet Spa, CY4Gate SpA, and Sys-dat S.P.A.. According to TipRanks, Nargi has an average return of 7.5% and a 58.33% success rate on recommended stocks.
In another report released today, Intesa Sanpaolo also maintained a Buy rating on the stock with a €6.70 price target.

